Your browser doesn't support javascript.
loading
Authors' Response to the Letter by Lamarca et al. Entitled "Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms".
Chatzellis, Eleftherios; Daskalakis, Kosmas; Angelousi, Anna; Tsoli, Marina; Alexandraki, Krystallenia I; Wachula, Ewa; Meirovitz, Amichay; Maimon, Ofra; Grozinsky-Glasberg, Simona; Gross, David; Kos-Kudla, Beata; Koumarianou, Anna; Kaltsas, Gregory.
Afiliação
  • Chatzellis E; First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece, lefterchatz@gmail.com.
  • Daskalakis K; 251 HAF and VA Hospital, Athens, Greece, lefterchatz@gmail.com.
  • Angelousi A; First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Tsoli M; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Alexandraki KI; First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Wachula E; First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Meirovitz A; First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Maimon O; Department of Clinical Oncology and Radiotherapy, Medical University of Silesia, Katowice, Poland.
  • Grozinsky-Glasberg S; Oncology Department and Radiation Therapy Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Gross D; Oncology Department and Radiation Therapy Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Kos-Kudla B; Neuroendocrine Tumor Unit, Department of Endocrinology and Metabolism, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Koumarianou A; Neuroendocrine Tumor Unit, Department of Endocrinology and Metabolism, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Kaltsas G; Department of Endocrinology and Neuroendocrine Neoplasms, Medical University of Silesia, Katowice, Poland.
Neuroendocrinology ; 110(1-2): 158-160, 2020.
Article em En | MEDLINE | ID: mdl-31597137
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Temozolomida Limite: Humans Idioma: En Revista: Neuroendocrinology Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Temozolomida Limite: Humans Idioma: En Revista: Neuroendocrinology Ano de publicação: 2020 Tipo de documento: Article